Subscribe to our news feed
A question?
4/21/2026
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
“We succeeded in surpassing last year’s record-breaking first quarter with organic growth in both net sales and order intake,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 0,8% while the order intake rose by 3,9% organically.
3/26/2026
Getinge publishes Annual Report for 2025
Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underlying profitability, continued regulatory progress, and an ambitious innovation agenda.
3/18/2026
Getinge’s iCast covered stent system expands U.S. offering with additional sizes
Getinge has received U.S. FDA Premarket Approval (PMA) for additional sizes of its iCast covered stent system, expanding treatment options for patients with occlusive disease. The approval includes a new 10 mm diameter by 59 mm length, new 32 mm lengths, and new 12 mm large diameter options.
Press Contacts
Caroline Örmgård
Phone: +46 10 335 0041
Lars Mattsson
Phone: +46 10 335 0043
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!